Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 ng » 5 g (Expand Search), 5 nm (Expand Search), 5 kg (Expand Search)
5 mg » 5 mm (Expand Search)
Showing 161 - 180 results of 21,090 for search '(((( 5 ng decrease ) OR ( 5 mg decrease ))) OR ( 50 ((ms decrease) OR (a decrease)) ))', query time: 0.66s Refine Results
  1. 161
    Fig 4 -

    Fig 4 - by Dalia Zaafar (6693017)

    Published 2022
    Save to List
    Saved in:
  2. 162
    Prevalence and anatomic level of stenosis ≥ 50% in either limb.

    Prevalence and anatomic level of stenosis ≥ 50% in either limb. by O. Stivalet (6890189)

    Published 2019
    Save to List
    Saved in:
  3. 163
    Fig 3 -

    Fig 3 - by Yan Shu (441370)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  4. 164
    Label-Free Quantitative Proteomic Analysis Reveals the Effects of Biogenic Silver Nanoparticles on Fusarium keratoplasticum and Their Therapeutic Potential in Galleria mellonella Larvae

    Label-Free Quantitative Proteomic Analysis Reveals the Effects of Biogenic Silver Nanoparticles on Fusarium keratoplasticum and Their Therapeutic Potential in Galleria mellonella L... by Glaucia Rigotto-Caruso (22057974)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 165
    EB (Ethyl Butyrate) as a Cosolvent of Electrolyte Tuning an Ultrathin CEI Membrane for Improving the Ultralow-Temperature Behaviors of LiNi<sub>0.8</sub>Co<sub>0.1</sub>Mn<sub>0.1</sub>O<sub>2</sub> Batteries

    EB (Ethyl Butyrate) as a Cosolvent of Electrolyte Tuning an Ultrathin CEI Membrane for Improving the Ultralow-Temperature Behaviors of LiNi<sub>0.8</sub>Co<sub>0.1</sub>Mn<sub>0.1<... by Lucheng Li (13753395)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 166
    EB (Ethyl Butyrate) as a Cosolvent of Electrolyte Tuning an Ultrathin CEI Membrane for Improving the Ultralow-Temperature Behaviors of LiNi<sub>0.8</sub>Co<sub>0.1</sub>Mn<sub>0.1</sub>O<sub>2</sub> Batteries

    EB (Ethyl Butyrate) as a Cosolvent of Electrolyte Tuning an Ultrathin CEI Membrane for Improving the Ultralow-Temperature Behaviors of LiNi<sub>0.8</sub>Co<sub>0.1</sub>Mn<sub>0.1<... by Lucheng Li (13753395)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  7. 167
    Relationship between decreased fluoride concentration and increased SO<sub>4</sub><sup>2-</sup> concentration in solution at different proportions of metaettringite.

    Relationship between decreased fluoride concentration and increased SO<sub>4</sub><sup>2-</sup> concentration in solution at different proportions of metaettringite. by Atsushi Iizuka (3184404)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 168
    Reference mutations versus background noise across replicates.

    Reference mutations versus background noise across replicates. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 169
    Analytical sensitivity and reproducibility.

    Analytical sensitivity and reproducibility. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 170
    Depth of coverage and heterogeneity of the mutation loci. x-axis, mutation loci in sample set one or two; y-axis, depth of coverage after UMI consolidation.

    Depth of coverage and heterogeneity of the mutation loci. x-axis, mutation loci in sample set one or two; y-axis, depth of coverage after UMI consolidation. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 171
    Quantification and accuracy of average VAF.

    Quantification and accuracy of average VAF. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 172
    Schematic overview of the cross-platform study.

    Schematic overview of the cross-platform study. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 173
    Impact of DNA extraction process on depth of coverage.

    Impact of DNA extraction process on depth of coverage. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 174
    Anti-CXCR3 group decreased number of specific CD8<sup>+</sup> T cells as well as polyfunctionality after infection with <i>T</i>. <i>cruzi</i>.

    Anti-CXCR3 group decreased number of specific CD8<sup>+</sup> T cells as well as polyfunctionality after infection with <i>T</i>. <i>cruzi</i>. by Camila Pontes Ferreira (6194006)

    Published 2020
    Save to List
    Saved in:
  15. 175
    Variation of pH with time; initial pH of 3.5.

    Variation of pH with time; initial pH of 3.5. by Atsushi Iizuka (3184404)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 176
    Alterations in the post-PM2.5 exposure sperm quality ( ±s).

    Alterations in the post-PM2.5 exposure sperm quality ( ±s). by Cao Wang (1500691)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 177
    Changes in blood pressure before, during and after regadenoson (RA) infusion.

    Changes in blood pressure before, during and after regadenoson (RA) infusion. by Joseph Rabin (7399436)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 178
    Diagram showing some of the factors that mediate cytokin storm following infection with COVID-19.

    Diagram showing some of the factors that mediate cytokin storm following infection with COVID-19. by Joseph Rabin (7399436)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 179
    Changes of plasma proinflammatory cytokines/chemokines during and after RA infusion.

    Changes of plasma proinflammatory cytokines/chemokines during and after RA infusion. by Joseph Rabin (7399436)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  20. 180
    Demographics of the COVID-19 patients who received regadenoson treatment.

    Demographics of the COVID-19 patients who received regadenoson treatment. by Joseph Rabin (7399436)

    Published 2023
    Subjects:
    Save to List
    Saved in:

Search Tools: